Skip to content
← Back to this collection

PUBLICATIONS · 26929274

The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
2016 Apr 28
First author
Olombel G

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Olombel G
      type
      Author
    2. name
      Guerin E
      type
      Author
    3. name
      Guy J
      type
      Author
    4. name
      Perrot JY
      type
      Author
    5. name
      Dumezy F
      type
      Author
    6. name
      de Labarthe A
      type
      Author
    7. name
      Bastie JN
      type
      Author
    8. name
      Legrand O
      type
      Author
    9. name
      Raffoux E
      type
      Author
    10. name
      Plesa A
      type
      Author
    11. name
      Wagner-Ballon O
      type
      Author
    12. name
      Cornet E
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Olombel G
      type
      Author
    2. name
      Guerin E
      type
      Author
    3. name
      Guy J
      type
      Author
    4. name
      Perrot JY
      type
      Author
    5. name
      Dumezy F
      type
      Author
    6. name
      de Labarthe A
      type
      Author
    7. name
      Bastie JN
      type
      Author
    8. name
      Legrand O
      type
      Author
    9. name
      Raffoux E
      type
      Author
    10. name
      Plesa A
      type
      Author
    11. name
      Wagner-Ballon O
      type
      Author
    12. name
      Cornet E
      type
      Author
    bibliography ids
    1. nci-bib-e0c408ce3c02a61a544ae3e7
    book metadata
    content sha256
    c4df56b10d08b342f85791236d6d449f6ad7d42fb253543e8850943f1f28c0ab
    document type
    citation
    dois
    1. 10.1182/blood-2016-01-689976
    electronic publication date
    display
    2016 Feb 29
    precision
    day
    year
    2016
    evidence scope
    bibliographic_metadata_only
    id
    pubmed:26929274
    immutable id
    pubmed:26929274@c4df56b10d08b342f85791236d6d449f6ad7d42fb253543e8850943f1f28c0ab
    journal
    abbreviation
    Blood
    issn electronic
    1528-0020
    issn print
    0006-4971
    issue
    17
    name
    Blood
    nlm unique id
    7603509
    pages
    2157-60
    volume
    127
    languages
    1. eng
    notices
    absence is not clearance
    true
    has correction metadata
    false
    has expression of concern metadata
    false
    has retraction in link
    false
    pubmed marks article retracted
    false
    pubmed marks retraction notice
    false
    relationships
      outcomes validated
      false
      pmid
      26929274
      provenance
      batch id
      fe5a46c92522c34737e8
      provider
      NCBI PubMed ESummary
      record sha256
      85f1a57c3af11a9e8aa9a2c2cac90290d08b2a0c85ef46191dc9aca0e02b28b3
      response sha256
      2c7bacd02d2ece3813daf1a0f92260c22884bd9268942fcca2088ab229bfb4d1
      retrieved at
      2026-09-09T23:47:17.939307+00:00
      publication date
      display
      2016 Apr 28
      precision
      day
      year
      2016
      publication types
      1. Clinical Trial
      2. Letter
      record status
      PubMed - indexed for MEDLINE
      schema version
      1.0
      source url
      https://pubmed.ncbi.nlm.nih.gov/26929274/
      title
      The level of blast CD33 expression positively impacts the effect of gemtuzumab ozogamicin in patients with acute myeloid leukemia.

      Preserved source evidence · Not medical advice